Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Hema Dave"'
Autor:
Hongyan Liu, Colleen Callahan, Shannon L Maude, Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Yimei Li, Kara Lynn Davis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Immunocompromised patients are at increased risk of SARS-CoV-2 infections. Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B
Externí odkaz:
https://doaj.org/article/6172d8b90c9540918dcb40c5c533faf9
Autor:
Scott Raskin, Stacey Van Pelt, Keri Toner, Preethi Bala Balakrishnan, Hema Dave, Catherine M. Bollard, Eric Yvon
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 296-306 (2021)
Summary: The synovial sarcoma X breakpoint 2 (SSX2) belongs to a multigene family of cancer-testis antigens and can be found overexpressed in multiple malignancies. Its restricted expression in immune-privileged normal tissues suggest that SSX2 may b
Externí odkaz:
https://doaj.org/article/1e9a41f1449c4bdfb967452ebe6ee458
Autor:
Andishe Attarbaschi, Oussama Abla, Leila Ronceray, Shweta Bansil, Simon Bomken, Birgit Burkhardt, Francecso Ceppi, Alan K.S. Chiang, Hema Dave, Alina Fedorova, Michael Henry, Janez Jazbec, Edita Kabickova, Rishi S. Kotecha, Jelena Lazic, Jan Loeffen, Natalia Miakova, Tomoo Osumi, Marta Pillon, Apostolos Pourtsidis, Charlotte Rigaud, Gevorg Tamamyan, Sneha Tandon, Anne Uyttebroeck, Jamie Verdu-Amoros, Wilhelm Woessmann, Grazyna Wrobel, Lisa Giulino-Roth
Publikováno v:
Blood Advances, Vol 3, Iss 24, Pp 4291-4297 (2019)
Externí odkaz:
https://doaj.org/article/3940ab067d484cbd8921888a63923d35
Autor:
Elizabeth M. Holland, Corina Gonzalez, Elliot Levy, Vladimir A. Valera, Heather Chalfin, Jacquelyn Klicka-Skeels, Bonnie Yates, David E. Kleiner, Colleen Hadigan, Hema Dave, Haneen Shalabi, Dennis D. Hickstein, Helen C. Su, Michael Grimley, Alexandra F. Freeman, Nirali N. Shah
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BK virus (BKV)-hemorrhagic cystitis (HC) is a well-known and rarely fatal complication of hematopoietic stem cell transplantation (HSCT). Treatment for BKV-HC is limited, but virus-specific T-cells (VST) represent a promising therapeutic option feasi
Externí odkaz:
https://doaj.org/article/6353932677624ec1a63e996fb77da356
Autor:
Sharon M. Castellino, Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen Mccarten, Terzah Horton, Steve Cho, Yue Wu, Angela Punnett, Hema Dave, Tara O. Henderson, Bradford S. Hoppe, Ann-Marie Charpentier, Frank G. Keller, Kara M. Kelly
Publikováno v:
HemaSphere, Vol 6, Pp 40-40 (2022)
Externí odkaz:
https://doaj.org/article/ffd0c0bb96874a749aa95d35af9fec09
Autor:
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell N. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2057-2068 (2019)
Abstract: Adoptive transfer of virus-specific T cells (VSTs) has been shown to be safe and effective in stem cell transplant recipients. However, the lack of virus-experienced T cells in donor cord blood (CB) has prevented the development of ex vivo
Externí odkaz:
https://doaj.org/article/c8185b6b4cdf45c295fb6e5a5bd795c2
Autor:
Hema Dave, Min Luo, J.W. Blaney, Shabnum Patel, Cecilia Barese, Conrad Russell Cruz, Elizabeth J. Shpall, Catherine M. Bollard, Patrick J. Hanley
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 13-21 (2017)
Umbilical cord blood (CB) has emerged as an effective alternative donor source for hematopoietic stem cell transplantation. Despite this success, the prolonged duration of immune suppression following CB transplantation and the naiveté of CB T cells
Externí odkaz:
https://doaj.org/article/aa567dccad5b4707904daf27e8d527ff
Autor:
Hema Dave, Miriam R Anver, Donna O Butcher, Patrick Brown, Javed Khan, Alan S Wayne, Sivasubramanian Baskar, Christoph Rader
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52655 (2012)
Despite high cure rates for pediatric B-lineage acute lymphoblastic leukemia (B-ALL), short-term and long-term toxicities and chemoresistance are shortcomings of standard chemotherapy. Immunotherapy and chemoimmunotherapy based on monoclonal antibodi
Externí odkaz:
https://doaj.org/article/d7cbb8cb33014e3c8c5d5f5be6d5c12b
Autor:
Christopher Jon Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia N. Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca Deyell, Jamie E Flerlage, Anna R. K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E Norris, Martha Pacheco, Faye K Willen, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino-Roth
Publikováno v:
Blood Advances.
Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with approximately 50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-fr
Autor:
Kimberly R. Jordan, Stephanie Rawlings-Rhea, Ashley Wilson, Annie Luong, Hema Dave, Hisham Abdel-Azim
Publikováno v:
Cytotherapy
Immune effector cell (IEC) therapies have revolutionized our approach to relapsed B-cell malignancies, and interest in the investigational use of IECs is rapidly expanding into other diseases. Current challenges in the analysis of IEC therapies inclu